8.44
price down icon7.15%   -0.65
after-market After Hours: 8.45 0.010 +0.12%
loading
Mind Medicine Inc stock is traded at $8.44, with a volume of 1.60M. It is down -7.15% in the last 24 hours and up +26.35% over the past month. Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
See More
Previous Close:
$9.09
Open:
$8.51
24h Volume:
1.60M
Relative Volume:
1.33
Market Cap:
$637.67M
Revenue:
$11.40B
Net Income/Loss:
$-95.73M
P/E Ratio:
-3.4449
EPS:
-2.45
Net Cash Flow:
$-64.37M
1W Performance:
-13.52%
1M Performance:
+26.35%
6M Performance:
+24.30%
1Y Performance:
+0.72%
1-Day Range:
Value
$7.9601
$8.83
1-Week Range:
Value
$7.9601
$9.79
52-Week Range:
Value
$4.70
$10.44

Mind Medicine Inc Stock (MNMD) Company Profile

Name
Name
Mind Medicine Inc
Name
Phone
212-220-6633
Name
Address
ONE WORLD TRADE CENTER, NEW YORK
Name
Employee
74
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
MNMD's Discussions on Twitter

Compare MNMD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MNMD
Mind Medicine Inc
8.44 686.78M 11.40B -95.73M -64.37M -2.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-28-25 Initiated Evercore ISI Outperform
Dec-20-24 Initiated Chardan Capital Markets Buy
Oct-14-24 Resumed Leerink Partners Outperform
Jul-24-24 Initiated ROTH MKM Buy
May-29-24 Initiated Robert W. Baird Outperform
Apr-15-24 Initiated Leerink Partners Outperform
Dec-05-23 Initiated Canaccord Genuity Buy
Dec-09-22 Resumed ROTH Capital Buy
Nov-16-22 Initiated RBC Capital Mkts Outperform
Aug-26-22 Initiated Oppenheimer Outperform
Aug-10-22 Initiated Cantor Fitzgerald Overweight
May-04-22 Initiated ROTH Capital Buy
Jun-28-21 Initiated Maxim Group Buy
View All

Mind Medicine Inc Stock (MNMD) Latest News

pulisher
Aug 03, 2025

What are the latest earnings results for Mind Medicine (MindMed) Inc.Invest confidently with advanced analysis tools - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Mind Medicine (MindMed) Inc. stock attracting strong analyst attentionFree Trading Psychology Coaching - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

How does Mind Medicine (MindMed) Inc. compare to its industry peersGet timely alerts on market opportunities - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Mind Medicine (MindMed) Inc. stockOutstanding capital returns - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Mind Medicine (MindMed) Inc. stockAccelerate your capital gains today - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Mind Medicine (MindMed) Inc. stockHigh-yield portfolio picks - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 02, 2025

How does Mind Medicine (MindMed) Inc. generate profit in a changing economyAchieve rapid financial growth with smart picks - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

When is Mind Medicine (MindMed) Inc. stock expected to show significant growthAchieve breakthrough investment performance - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

How volatile is Mind Medicine (MindMed) Inc. stock compared to the marketAI Powered Signals For Consistent Profits - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 01, 2025

Unraveling the Sharp Drop in Mind Medicine (MNMD.O): A Technical and Order-Flow Deep Dive - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

Mind Medicine Inc's Q2 2025 Earnings Call Highlights: Strong Financial Position and Strategic Advancements in MM-120 ODT Trials - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

Earnings call transcript: MindMed Q2 2025 reveals cash runway into 2027 - Investing.com Canada

Aug 01, 2025
pulisher
Aug 01, 2025

Mind Medicine (MindMed) Q2 2025 Earnings Call Transcript - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo.co

Aug 01, 2025
pulisher
Aug 01, 2025

Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strat - GuruFocus

Aug 01, 2025
pulisher
Aug 01, 2025

Mind Medicine Advances Phase III Trials for Anxiety and Depression Treatment, Appoints New CFO - AInvest

Aug 01, 2025
pulisher
Jul 31, 2025

MindMed August 2025 presentation slides: Phase 3 trials advance with $238M cash runway - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

MindMed August 2025 presentation slides: Phase 3 trials advance with $238M cash runway By Investing.com - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 31, 2025

MindMed Reports Strong Q2 2025 Financial Results - TipRanks

Jul 31, 2025
pulisher
Jul 31, 2025

MindMed Reports Q2 2025 Financial Results and Business Updates - Stock Titan

Jul 31, 2025
pulisher
Jul 31, 2025

What is the risk reward ratio of investing in Mind Medicine (MindMed) Inc. stockEntry Signal Growth Plan That Work - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What are the technical indicators suggesting about Mind Medicine (MindMed) Inc.Chart Pattern Forecasts For Consistent Profits - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-31 05:18:02 - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

What risks could impact Mind Medicine (MindMed) Inc. stock performanceFree Access to Investment Community - beatles.ru

Jul 30, 2025
pulisher
Jul 29, 2025

Custom Dashboard Highlights Mind Medicine (MindMed) Inc. Price MomentumConservative Long Term Growth Plans Under Review - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Mind Medicine MNMD 2025Q2 Earnings Preview Upside Potential on Strong Analyst Ratings - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-29 03:31:44 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 17:15:17 - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Mind Medicine (MindMed) Inc. in the next 12 monthsInvest smarter with real-time trading alerts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How many analysts rate Mind Medicine (MindMed) Inc. as a “Buy”Discover undervalued stocks before they soar - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Is Mind Medicine (MindMed) Inc. a good long term investmentTriple-digit returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jul 25, 2025
pulisher
Jul 24, 2025

Mind Medicine: Heading In The Right Direction (NASDAQ:MNMD) - Seeking Alpha

Jul 24, 2025
pulisher
Jul 24, 2025

MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025 - FinancialContent

Jul 24, 2025
pulisher
Jul 23, 2025

All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy - MSN

Jul 23, 2025
pulisher
Jul 22, 2025

Mind Medicine (MindMed) Inc. Stock Analysis and ForecastExplosive capital appreciation - jammulinksnews.com

Jul 22, 2025

Mind Medicine Inc Stock (MNMD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):